第八届监事会第四次会议决议公告 证券代码：002119 证券简称：康强电子 公告编号：2025-032 宁波康强电子股份有限公司 经认真审议，与会监事以记名投票表决的方式通过以下议案： (一)以 3 票同意、0 票弃权、0 票反对的表决结果审议通过《2025 年半年 度报告全文与摘要》。 经审核，监事会认为董事会编制和审核的公司 2025 年半年度报告的程序符 合法律、行政法规和中国证监会的规定，报告的内容真实、准确、完整地反映了 公司的实际情况，不存在任何虚假记载、误导性陈述或者重大遗漏。 (二)以 3 票同意、0 票弃权、0 票反对的表决结果审议通过《关于以自有资 产向银行申请抵押融资的议案》。 三、备查文件 1、第八届监事会第四次会议决议。 本公司及监事会全体成员保证信息披露的内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 特此公告。 一、监事会会议召开情况 宁波康强电子股份有限公司第八届监事会第四次会议通知于 2025 年 8 月 5 日以电子邮件方式发出，会议于 2025 年 8 月 15 日以通讯表决的方式召开，应参 加会议监事 3 人，实际参加会议监事为 3 人。本次会议由监事会主 ...

证券代码：002119 证券简称：康强电子 公告编号：2025-031 宁波康强电子股份有限公司 第八届董事会第四次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 宁波康强电子股份有限公司（以下简称"公司"）第八届董事会第四次会议 通知于 2025 年 8 月 5 日以电子邮件方式发出，会议于 2025 年 8 月 15 日以通讯 表决的方式召开，应参加会议董事 7 人，实际参加会议董事 7 人。本次会议由董 事长叶骥先生主持，公司监事、高级管理人员列席了会议。本次会议的召开符合 《公司法》和《公司章程》的相关规定。 二、董事会会议审议情况 （一）以 7 票同意、0 票弃权、0 票反对的表决结果审议通过《2025 年半年 度报告全文与摘要》。 具体内容详见公司同日刊登于《证券时报》、《上海证券报》、《中国证券 报》、巨潮资讯网《2025年半年度报告摘要》以及在巨潮资讯网披露的《2025 年半年度报告全文》。 宁波康强电子股份有限公司董事会 （二）以 7 票同意、0 票弃权、0 票反对的表决结果审议通过《关于以自有 资产向银 ...

康强电子8月18日晚间披露半年报，公司上半年实现营业收入9.71亿元，同比下降0.37%；归属于上市公 司股东的净利润5948.4万元，同比增长26.23%；基本每股收益0.16元。 ...

宁波康强电子股份有限公司 2025 年半年度报告全文 宁波康强电子股份有限公司 2025 年半年度报告 2025 年 8 月 1 宁波康强电子股份有限公司 2025 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容 的真实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担 个别和连带的法律责任。 公司负责人叶骥、主管会计工作负责人殷夏容及会计机构负责人(会计主 管人员)殷夏容声明：保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本次半年报的董事会会议。 本报告中如有涉及未来的计划、行业预测等前瞻性陈述，均不构成公司 对任何投资者的实质承诺，投资者及相关人士均应当对此保持足够的风险认 识，并且应当理解计划、预测与承诺之间的差异。敬请注意！ 公司计划不派发现金红利，不送红股，不以公积金转增股本。 2 1、载有公司负责人叶骥先生、主管会计工作负责人殷夏容女士、会计机构负责人殷夏容女士签名并盖章的财务报表。 2、报告期内在中国证监会指定报纸上公开披露过的所有公司文件的正本及公告的原件。 3、经公司法定代表人签名并加盖公章的 ...

Group 1 - Tianeng Heavy Industry plans to reduce its shareholding by up to 2.94%, totaling no more than 30.08 million shares [1] - Huafa Co. has received approval from the China Securities Regulatory Commission to issue convertible bonds to specific investors [1] - ST Jiaotou has been identified as the first candidate for the general contracting of a project with a total investment of 58.28 million yuan [1] Group 2 - Pizaihuang's subsidiary plans to invest 200 million yuan in a health industry investment fund with a target size of 1 billion yuan [2] - ST Weihai has been selected as a candidate for a design and construction project with a bid of 156 million yuan [4] - Kangqiang Electronics plans to reduce its shareholding by up to 1%, totaling no more than 3.75 million shares [6] Group 3 - Zongsheng Pharmaceutical's vice president plans to reduce his shareholding by up to 900,000 shares [6] - Tapai Group reported a net profit of 435 million yuan for the first half of the year, a year-on-year increase of 92.47% [7] - Tapai Group plans to repurchase shares worth between 50 million and 100 million yuan [7] Group 4 - Xinghua Co.'s subsidiary has completed annual maintenance and resumed production [8] - Huaxi Co. intends to acquire 100% equity of Xiefeng Cotton and Hemp for 90 million yuan [9] - Mind Electronics' major shareholders plan to reduce their holdings by a total of 4% [10] Group 5 - Tianhe Co.'s director plans to reduce his shareholding by up to 0.15% [11] - Longxin Zhongke's shareholders plan to transfer a total of 1.37% of the company's shares through a private transfer [12] - Kory Technology's major shareholders plan to reduce their holdings by up to 3.03% [13] Group 6 - Hehua Co. is undergoing a change in actual control, with stock resuming trading [14] - Focus Media plans to acquire 100% of New潮传媒 for 8.3 billion yuan [15] - Lionhead Co. intends to acquire 97.44% of Lipu Technology for 662 million yuan [16] Group 7 - ST Tianmao's major shareholder is planning a significant matter, leading to a temporary suspension of stock trading [18] - Lianjian Technology plans to acquire 60% of Zhongren Tongce for 21 million yuan [19]

Core Viewpoint - On August 6, no A-share listed companies disclosed any increase in shareholding, while 23 companies announced share reductions by their shareholders [1] Summary by Category Share Reduction Details - Keri Technology: Shareholders plan to reduce their holdings by no more than 3.03% of the company's shares [2] - Tianhe Co.: Director and senior management member Luo Xuanbin plans to reduce holdings by no more than 0.15% [2] - Mind Electronics: Shareholders intend to reduce holdings by no more than 4% of the total share capital [2] - Maidi Technology: Shareholder Wang Jianhua plans to reduce holdings by no more than 0.2321% [2] - Tianneng Heavy Industry: Specific shareholder Zheng Xu plans to reduce holdings by no more than 30.0845 million shares [2] - Kabeiyi: Directors and senior management plan to reduce their holdings [2] - Jingsheng Co.: Shareholder Xinrui Jicheng plans to reduce holdings by no more than 3% [2] - Anlian Ruishi: Huiwen Tianfu and Qi Liang plan to reduce a total of no more than 700,000 shares [2] - Lichang Food: Shareholders Li Gao Xing and Li Gao Chuang plan to reduce their holdings [2] - Shuyuan Pingmin: Controlling shareholder plans to reduce holdings by no more than 2% [2] - Qianhong Pharmaceutical: Shareholders holding more than 5% plan to reduce holdings by no more than 2.09 million shares [2] - Zhongsheng Pharmaceutical: Director and executive Long Chunhua plans to reduce holdings by no more than 900,000 shares [2] - Kangqiang Electronics: Shareholder Si Maishi plans to reduce holdings by no more than 1% [2] - Pulutong: Shareholders plan to reduce holdings by no more than 0.98% [2] - Binhua Co.: Shareholder Zhang Zhongzheng plans to reduce holdings by no more than 0.8211% [2] - Kanshe Co.: Five individual shareholders plan to reduce holdings by no more than 0.99% [2] - Haoyuan Pharmaceutical: Su Xin Fund plans to reduce holdings by no more than 3% [2] - Diweier: Shareholders plan to reduce holdings by no more than 0.82% [2] - Dongfang Guoxin: Controlling shareholder reduced holdings by 2.68 million shares on August 5 [2] - Feilin Geer: During stock price fluctuations, CEO Liu Dunyin reduced holdings by 8,600 shares [2] - Yongxin Optical: Angao International plans to reduce holdings by no more than 200,000 shares [2] - Wuzhou Special Paper: Controlling shareholder's concerted action plans to reduce holdings by no more than 0.36% [2] - Tianyang New Materials: Zhuhai Hengqin Caidong Fund plans to reduce holdings by no more than 3% [2]

Group 1: Company Performance - BeiGene reported a net profit of 450 million yuan for the first half of 2025, marking a turnaround from losses in the previous year, with product revenue increasing by 45.8% to 17.36 billion yuan and total revenue rising by 46.0% to 17.52 billion yuan [1] - CITIC Securities announced that Huaxia Fund achieved an operating income of 4.258 billion yuan and a net profit of 1.123 billion yuan in the first half of 2025, with total comprehensive income of 1.106 billion yuan [3] - Shanghai Pudong Development Bank's net profit for the first half of 2025 was 29.737 billion yuan, reflecting a year-on-year growth of 10.19%, with total operating income of 90.559 billion yuan, up 2.62% [6] - Xianhe Co. plans to invest approximately 11 billion yuan in a new integrated high-performance paper-based material project, with an expected annual output value of about 5.15 billion yuan from the first phase [7] - Shengmei Shanghai reported a net profit of 696 million yuan for the first half of 2025, representing a year-on-year increase of 56.99% [14] Group 2: Regulatory and Corporate Actions - Sino Medical's subsidiary received breakthrough medical device designation from the FDA for its intracranial atherosclerosis treatment product, marking it as the first of its kind globally [2] - *ST Dongtong's actual controller and chairman is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws [8] - Tianyang Technology is planning to purchase equity in Tonglian Financial Services, with key transaction details still under negotiation [10] - Dongfang Guoxin's major shareholder reduced their stake by 2.68 million shares, decreasing their total shareholding from 27.06% to 26.82% [5] - Filinger's president reduced his holdings by 8,600 shares during a period of stock price volatility, while other executives did not sell shares [4]

Group 1: Company Performance - BeiGene reported a net profit of 450 million yuan for the first half of 2025, marking a turnaround from losses in the previous year, with product revenue increasing by 45.8% to 17.36 billion yuan and total revenue rising by 46.0% to 17.52 billion yuan [1] - CITIC Securities announced that Huaxia Fund achieved a net profit of 1.123 billion yuan in the first half of 2025, with total operating income of 4.258 billion yuan and total comprehensive income of 1.106 billion yuan [1] - Shanghai Pudong Development Bank reported a net profit of 29.737 billion yuan for the first half of 2025, reflecting a year-on-year growth of 10.19%, with total operating income of 90.559 billion yuan, up 2.62% [4] - Xianhe Co., Ltd. plans to invest approximately 11 billion yuan in a new integrated high-performance paper-based material project, with an expected annual output value of about 5.15 billion yuan from the first phase [5] - Shunbo Alloy reported a net profit growth of 110.56% year-on-year for the first half of 2025 [12] Group 2: Regulatory and Corporate Actions - Sino Medical announced that its subsidiary received breakthrough medical device designation from the FDA for a new intracranial atherosclerosis treatment product, marking a significant milestone as the first of its kind globally [1] - *ST Dongtong's actual controller and chairman is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws [6][7] - Tianyang Technology is planning to purchase equity in Tonglian Jinfu and related companies, with key transaction details still under negotiation [8] - Filinger reported stock price fluctuations, with the president reducing his holdings by 8,600 shares during a period of abnormal trading activity [2] - Dongfang Guoxin's controlling shareholder reduced their stake by 2.68 million shares, decreasing their total shareholding from 27.06% to 26.82% [3]

证券代码：002119 证券简称：康强电子 公告编号：2025-030 宁波康强电子股份有限公司 关于持股 5%以上股东减持股份的预披露公告 股东宁波司麦司电子科技有限公司、郑康定先生保证向本公司提供的信息内 容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 持有宁波康强电子股份有限公司(以下简称"公司")股份 28,222,707 股（占 公司总股本比例 7.52%）的股东宁波司麦司电子科技有限公司(以下简称"司麦 司")因自身资金需求计划自本公告披露之日起十五个交易日后的三个月内以集 中竞价方式减持公司股份不超过 3,752,840 股（占公司总股本比例不超过 1%）。 公司于近日收到持股 5%以上股东司麦司及其一致行动人郑康定先生出具的 《关于计划减持公司股份的告知函》，现将相关具体情况公告如下： 一、股东基本情况 截止本公告日，拟减持股东及一致行动人持有公司股份情况如下： 股东名称 股东身份 持股数量（股） 占公司总股本比例 宁波司麦司电子科 5%以上股东，非公 28,222,707 7.52% 技有限公司 司第一 ...

康强电子（002119）(002119.SZ)公告，公司股东宁波司麦司电子科技有限公司(简称"司麦司")计划自本 公告披露之日起十五个交易日后的三个月内以集中竞价方式减持公司股份不超过375.28万股(占公司总 股本比例不超过1%)。 ...